RecruitingNCT06758271
Special Drug Use-results Survey for Long-term Use（Avacopan）
Special Drug Use-results Survey for Long-term Use
Sponsor
Kissei Pharmaceutical Co., Ltd.
Enrollment
250 participants
Start Date
Jul 29, 2022
Study Type
OBSERVATIONAL
Conditions
Summary
The purpose of this survey is evaluating the safety and efficacy of long-term administration of avacopan for Japanese patients with microscopic polyangiitis or granulomatosis with polyangiitis under actual conditions of use.
Eligibility
Inclusion Criteria1
- Patients with granulomatosis with polyangiitis or microscopic polyangiitis who are treatment with avacopan
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
DRUGAvacopan
oral administration
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06758271